PMEDF (QScreen AI) Total Liabilities: $0.92 Mil (As of Jan. 2026)


What is QScreen AI Total Liabilities?

QScreen AI PMEDF +57.06% Total Liabilities is $0.92 Mil as of Jan. 2026. The stock has 1 warning sign investors should review.

QScreen AI's Total Liabilities for the quarter that ended in Jan. 2026 was $0.92 Mil.

QScreen AI's quarterly Total Liabilities increased from Jul. 2025 ($0.88 Mil) to Oct. 2025 ($0.92 Mil) and increased from Oct. 2025 ($0.92 Mil) to Jan. 2026 ($0.92 Mil).

QScreen AI's annual Total Liabilities increased from Jan. 2024 ($0.47 Mil) to Jan. 2025 ($1.01 Mil) but then declined from Jan. 2025 ($1.01 Mil) to Jan. 2026 ($0.92 Mil).

QScreen AI Total Liabilities Historical Data

* Premium members only.

The historical data trend for QScreen AI's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QScreen AI Total Liabilities Chart

QScreen AI Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Total Liabilities
Get a 7-Day Free Trial 0.28 0.65 0.47 1.01 0.92

QScreen AI Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 0.91 0.88 0.92 0.92

QScreen AI Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

QScreen AI's Total Liabilities for the fiscal year that ended in Jan. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.924+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.92

Total Liabilities=Total Assets (A: Jan. 2026 )-Total Equity (A: Jan. 2026 )
=0.37--0.553
=0.92

QScreen AI's Total Liabilities for the quarter that ended in Jan. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.924+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.92

Total Liabilities=Total Assets (Q: Jan. 2026 )-Total Equity (Q: Jan. 2026 )
=0.37--0.553
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.92 Mil mean?
QScreen AI (PMEDF) has a Total Liabilities of $0.92 Mil as of Jan. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for QScreen AI and its competitors.
Is QScreen AI's Total Liabilities too high?
QScreen AI's current Total Liabilities is $0.92 Mil.
How does QScreen AI's Total Liabilities compare to ABT and SYK?
QScreen AI's Total Liabilities of $0.92 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for QScreen AI and its competitors. QScreen AI's current Total Liabilities is $0.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QScreen AI stock overvalued right now?
QScreen AI (PMEDF) has a current Total Liabilities of $0.92 Mil. The current Total Liabilities is $0.92 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For QScreen AI (PMEDF), the current Total Liabilities is $0.92 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

QScreen AI Business Description

Other Exchanges 3QP:GermanyQAI:Canada
Address 40 King Street West, Suite 2400, P.O. Box 215, Scotia Plaza, Toronto, ON, CAN, M5H 3Y2
QScreen AI Inc is focused on developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. The company's business is focused on artificial intelligence (AI) technologies targeting two specific areas: workplace health and safety and healthcare. It is building a proprietary artificial intelligence engine with quantum inspired computing and physiological sensing to clinical and occupational health assessments across correctional facilities, addiction medicine rehabilitation, and industrial workforce screening in multiple jurisdictions. It operates in single segment.